Applicant, as named in the Orange Book

Esteve

Next listed expiry: Quzyttir on 28 Feb 2030. 1 products with live protection, 3 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Quzyttir NDA 211415 cetirizine hydrochloride	cetirizine hydrochloride	28 Feb 2030 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (3)

Drug	Ingredient	Earliest generic entry	Basis
Lysodren NDA 016885 mitotane	mitotane	open now no listed protection	no listed protection
Metopirone NDA 012911 metyrapone	metyrapone	open now no listed protection	no listed protection
Prialt NDA 021060 · 3 strengths ziconotide acetate	ziconotide acetate	open now no listed protection	no listed protection